Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreightons Regulatory News (CRL)

Share Price Information for Creightons (CRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 4.00 (17.391%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 25.00
CRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

21 Nov 2012 11:10

RNS Number : 6768R
Creightons PLC
21 November 2012
 



Creightons plc Group

Interim financial report

For the six months ended 30 September 2012

 

Chairman's Statement

 

The Group has continued to make progress in the first half of the year recording improved profit before tax of £38,000 in the six months to 30 September 2012 (2011: £6,000).

 

The profit improvement came on the back of increased sales which rose by 9.4% to £8,374,000 (2011: £7,657,000). We have continued the trend shown over the last two years of increasing sales of our own branded products which have increased by 34% on a constant currency basis compared to last year and now account for 41% of sales in the first six months to 30 September 2012 (2011: 33%). This growth has been brought about to a large extent by a greater emphasis on widening the distribution of our key brands such as The Real Shaving Company and Twisted Sista. We have also seen significant growth in sales of brands targeted at the discount market. We have continued to increase the presence of our brands in the North American market with a larger customer base and have also started to distribute third party products. Sales to our private label and contract customers have declined slightly over the period. Sales of seasonal gifts to private label customers have continued to fall and now account for less than 1% of sales in the period compared to 2% last year and 10% three years ago.

 

Our gross margins have improved to 42.0% in the six months to 30 September 2012 (2011: 41.3%), in the main due to improved productivity and changes in sales mix. Raw material price increases have moderated in the period and have not placed the same pressure on margins as previous periods. We are continuing our efforts to improve our margins through product re-engineering, targeted investment in plant and machinery and focused price increases.

 

We have refocused our sales force in the period under review in order to drive wider distribution of our brands and have continued with an aggressive new product development programme in support of our customers, although new product development activity is lower than in the same period last year. We have also continued to support our branded sales expansion with increased promotions, advertising and public relations activity in this period. This is likely to continue where we consider it supports the expansion of our branded sales.

 

Whilst we continue to be cautious regarding the underlying level of retail sales, particularly in the current economic environment, we believe our strategy of developing strong value driven products will help counteract this uncertainty and is enabling us to build a more robust branded product franchise. We anticipate a number of new product launches with our private label and contract customers helping to maintain sales in the second six months of our financial year.

 

Stock levels have increased in line with our sales growth and to support new launch activity planned just after the period end. We have however increased our resources and emphasis on reducing stock levels whilst maintaining the excellent customer service levels we currently enjoy.

 

Our cash position has fallen slightly over the six months to 30 September 2012 as we have invested in stocks to support new product launches in the final months of 2012.

 

I believe that this half year's increased sales of £8,374,000 and pre-tax profit of £38,000 is a good performance in the current economic climate and the continued increase in sales of branded products significantly strengthens the Group's core business.

 

 

 

W O McIlroy

Executive Chairman 20 November 2012

 

 

 

Responsibility statement

 

We confirm that to the best of our knowledge:

a) The condensed set of financial statements has been prepared in accordance with IAS 34:

b) The interim management report includes a fair review of the information required by DTR 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and

c) The interim management report includes a fair review of the information required by DTR 4.2.8R (disclosure of material related party transactions and changes therein).

 

By order of the Board

 

 

 

 

Nicholas O'Shea

Company Secretary and Director

 

 

 

 

Creightons plc

Interim financial report

For the six months ended 30 September 2012

 

Consolidated income statement - unaudited

 

 

Six months ended 30 September

Year ended 31 March

2012

2011

2012

Note

£000

£000

£000

 

Revenue

8,374

7,657

16,333

Cost of sales

(4,858)

(4,495)

(9,461)

Gross profit

3,516

3,162

6,872

Distribution costs

(360)

(323)

(686)

Administrative expenses

(3,102)

(2,811)

(5,929)

Operating profit

54

28

257

Finance costs

(16)

(22)

(34)

Profit/(loss) before tax

38

6

223

Taxation

-

-

-

Profit/(loss) for the period from continuing operations attributable to the equity holders of the parent company

38

6

223

 

Earnings per share

 

Basic

2

0.07p

0.01p

0.41p

Diluted

2

0.06p

0.01p

0.37p

 

 

 

 

Consolidated statement of comprehensive income

 

 

Six months ended 30 September

Year ended 31 March

2012

2011

2012

£000

£000

£000

Profit for the period from continuing operations

38

6

223

 

Exchange differences on translating of foreign operations

-

(9)

-

Total comprehensive income for the period attributable to the equity holders of the company

38

(3)

223

 

 

 

 

 

Consolidated balance sheet - unaudited

 

 

30 September

31 March

2012

2011

2012

£000

£000

£000

Non-current assets

Goodwill

345

345

346

Other intangible assets

265

258

262

Property, plant and equipment

542

630

556

1,152

1,233

1,164

Current assets

Inventories

3,695

3,530

3,271

Trade and other receivables

3,008

3,342

3,040

Cash and cash equivalents

33

61

106

6,736

6,933

6,417

Total assets

7,888

8,166

7,581

Current liabilities

Trade and other payables

2,923

2,113

2,604

Obligations under finance leases

19

27

19

Short term borrowings

786

2,135

838

3,728

4,275

3,461

Net current assets

3,008

2,658

2,956

Non-current liabilities

Obligations under finance leases

57

70

67

Total liabilities

3,785

4,345

3,528

Net assets

4,103

3,821

4,053

Equity

Share capital

545

545

545

Share premium account

1,231

1,231

1,231

Other reserves

38

38

38

Share-based payment reserve

51

37

44

Retained earnings

2,266

2,011

2,228

Translation reserve

(28)

(41)

(33)

Total equity attributable to the equity shareholders

4,103

3,821

4,053

 

 

 

 

 

Statement of changes in shareholders equity - unaudited

 

 

Share capital

 

Share premium account

Other reserves

Share-based payment reserve

Retained earnings

Translation reserve

Total

£000

£000

£000

£000

£000

£000

£000

Balance at 1 April 2011

543

1,229

38

30

2,005

(32)

3,813

Issue of share capital

2

2

-

-

-

-

4

Profit for six months ended 30 September 2011

-

-

-

-

6

-

6

Debit to equity for share based payments

-

-

-

7

-

-

7

Exchange differences on translation of foreign operations

-

-

-

-

-

(9)

(9)

Balance at 30 September 2011

545

1,231

38

37

2,011

(41)

3,821

 

Profit for six months ended 31 March 2012

-

-

-

-

217

-

217

Debit to equity for share based payments

-

-

-

7

-

-

7

Exchange differences on translation of foreign operations

-

-

-

-

-

8

8

Balance at 31 March 2012

545

1,231

38

44

2,228

(33)

4,053

Profit for six months ended 30 September 2012

-

-

-

-

38

-

38

Debit to equity for share based payments

-

-

-

7

-

-

7

Exchange differences on translation of foreign operations

-

-

-

-

-

5

5

Balance at 30 September 2012

545

1,231

38

51

2,266

(28)

4,103

 

 

 

 

 

 

 

 

Consolidated cash flow statement - unaudited

 

 

Six months ended

30 September

Year ended

31 March

2012

2011

2012

£000

£000

£000

 

Net cash inflow/(outflow) from operating activities

195

(1,150)

339

Cash flow from investing activities

Purchase of property, plant and equipment

(48)

(286)

(308)

Goodwill

-

(3)

-

Expenditure on intangible assets

(158)

(215)

(333)

Net cash used in investing activities

(206)

(504)

(641)

Cash flow from financing activities

Repayment of finance lease obligations

(10)

(8)

(18)

New Finance Lease obligations-

-

97

97

Proceeds on issue of shares

-

4

4

Increase in bank loans

(52)

1,524

227

Net cash from financing activities

(62)

1,617

310

Net (decrease)/increase in cash and cash equivalents

(73)

(37)

8

Cash and cash equivalents at start of period

106

96

96

Effect of foreign exchange rate changes

-

2

2

Cash and cash equivalents at end of period

33

61

106

 

 

 

Notes to the interim financial report

 

1. Basis of preparation

 

The condensed financial statements in this Interim Report have been prepared in accordance with the requirements of IAS 34 'Interim Financial Reporting' as adopted by the European Union.

 

As required by the Disclosure and Transparency Rules of the UK's Financial Services Authority, the condensed set of financial statements has been prepared by applying the accounting policies and presentation that were applied in the preparation on the Company's published consolidated financial statements for the year ended 31 March 2012, which were prepared in accordance with International Financial Reporting Standards as adopted by the European Union.

 

The condensed interim financial statements for the six months ended 30 September 2012 and the comparative figures for the six months ended 30 September 2011 are unaudited and have not been reviewed by the Auditors. The summary financial statements for the year ended 31 March 2012 represent an abbreviated version of the Group's full financial statements for that year, on which the Auditors issued an unqualified audit report and which have been filed with the Registrar of Companies.

 

2. Earnings per share

 

The calculation of the basic and diluted earnings per share is based on the following data:

 

 

Six months ended

30 September

Year ended

31 March

2012

2011

2011

£000

£000

£000

Earnings

Net profit attributable to the equity holders of the parent company

38

6

223

 

Six months ended

30 September

Year ended

31 March

2012

2011

2012

Number

Number

Number

Number of shares

Weighted average number of ordinary shares for the purposes of basic earnings per share

54,478,876

54,478,876

54, 478,876

Effect of dilutive potential ordinary shares relating to Share options

5,376,550

5,426,550

5,376,550

Weighted average number of ordinary shares for the purposes of diluted earnings per share

59,855,426

59,905,426

59, 855,426

 

 

 

3. Related party transactions

 

The related party transactions that occurred in the six months ended 30 September 2012 are not materially different in size or nature to those reported in the Company's Annual Report for the year ended 31 March 2012.

 

 

4. Availability of Interim Report

 

The Interim Report is being sent to shareholders. Further copies can be obtained from the Company's Registered Office, 1210 Lincoln Road, Peterborough, PE4 6ND.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BKDDPKBDDKDB
Date   Source Headline
15th Mar 202410:52 amRNSBlock listing Interim Review
7th Mar 20247:00 amRNSDirectorate Change
4th Dec 20237:00 amRNSHalf-year Report
27th Nov 20237:00 amRNSDirectorate Change
25th Sep 202311:50 amRNSDirector/PDMR Shareholding
15th Sep 20235:24 pmRNSBlock listing Interim Review
14th Sep 20239:52 amRNSResult of AGM
1st Sep 20235:17 pmRNSDirector/PDMR Shareholding
1st Sep 20235:05 pmRNSDirector/PDMR Shareholding
25th Aug 20233:32 pmRNSDirector/PDMR Shareholding
31st Jul 20232:53 pmRNSReplacement: Director/PDMR Shareholding
24th Jul 202311:54 amRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSAudited preliminary results
31st Mar 202310:49 amRNSTotal Voting Rights
17th Mar 20237:00 amRNSBlock listing Interim Review
16th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Jan 20232:05 pmRNSSecond Price Monitoring Extn
27th Jan 20232:00 pmRNSPrice Monitoring Extension
12th Jan 20232:05 pmRNSSecond Price Monitoring Extn
12th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Dec 202211:05 amRNSSecond Price Monitoring Extn
30th Dec 202211:00 amRNSPrice Monitoring Extension
20th Dec 20224:40 pmRNSSecond Price Monitoring Extn
20th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20227:00 amRNSHalf-year Report
29th Nov 20224:41 pmRNSSecond Price Monitoring Extn
29th Nov 20224:36 pmRNSPrice Monitoring Extension
25th Nov 20227:00 amRNSInterim Results 2022 - announcement, presentations
27th Sep 20227:00 amRNSUpdate on Emma Hardie, Trading in own shares & TVR
20th Sep 20229:22 amRNSBlock Listing Update
24th Aug 20221:01 pmRNSResult of AGM
12th Jul 20229:05 amRNSSecond Price Monitoring Extn
12th Jul 20229:00 amRNSPrice Monitoring Extension
12th Jul 20227:00 amRNSResults for year to end 31 March 2022
11th Jul 20227:00 amRNSPreliminary Results, investor/analyst presentation
4th Jul 20224:42 pmRNSTotal Voting Rights
7th Jun 20223:28 pmRNSTotal Voting Rights
3rd May 20226:09 pmRNSTotal Voting Rights
12th Apr 20224:33 pmRNSDirector/PDMR Dealing, Total Voting Rights
21st Mar 202211:37 amRNSBlock listing Interim Review
7th Mar 20229:59 amRNSTotal Voting Rights
14th Jan 20222:58 pmRNSTotal Voting Rights
30th Dec 20217:00 amRNSHalf-year Report
15th Dec 20212:52 pmRNSNotice of Interim Results & Investors Presentation
6th Dec 20215:38 pmRNSTotal Voting Rights
25th Nov 20216:18 pmRNSDirector/PDMR Shareholding and Total Voting Rights
23rd Nov 20214:49 pmRNSDirector/PDMR Shareholding
18th Nov 202111:55 amRNSDirector/PDMR Shareholding
17th Nov 20211:58 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.